Precise Determination of TSH Receptor Antibody Activity in Serum Containing Bovine TSH (bTSH) Binding Antibody by Absorption Using Denatured bTSH or Sheep FSH

Thyroid ◽  
1996 ◽  
Vol 6 (4) ◽  
pp. 295-299 ◽  
Author(s):  
TAKEHIRO INUI ◽  
TSUYOSHI KOUKI ◽  
HIDETOSHI OKABE ◽  
YUKIO OCHI ◽  
TAKASHI HACHIYA ◽  
...  
Keyword(s):  
Precise Determination ◽  
Tsh Receptor ◽  
Antibody Activity ◽  
Receptor Antibody ◽  
Tsh Receptor Antibody ◽  
Binding Antibody ◽  
Bovine Tsh

Evidence of intrathyroidal accumulation of TSH receptor antibody in Graves' disease

1992 ◽  
Vol 126 (5) ◽  
pp. 416-418 ◽  
Author(s):  
Akira Sugenoya ◽  
Shinya Kobayashi ◽  
Yoshio Kasuga ◽  
Hiroyuki Masuda ◽  
Minoru Fujimori ◽  
...  
Keyword(s):  
Peripheral Blood ◽  
Venous Blood ◽  
Tsh Receptor ◽  
Surgical Patients ◽  
Graves Disease ◽  
Receptor Antibody ◽  
Tsh Receptor Antibody ◽  
Serial Determination ◽  
Immunological Condition

To clarify the intrathyroidal accumulation of TSH receptor antibody (TR-ab) produced in the thyroid, adrenalin was injected directly into the thyroid artery of patients with Graves' disease during surgery, allowing serial determination of the TR-ab levels in the thyroidal venous blood. Nine surgical patients (3M and 6F) with Graves' disease and receiving anti-thyroid drugs preoperatively for a period of one to four years were enrolled in this study. Comparison between pre- and post-treatment TR-ab levels revealed continuous increments from the pretreatment levels within 15 min of the injection in five (55.6%) of the nine patients. In three of the five patients, TR-ab levels that had been negative before adrenalin injection became positive 1 min after injection. It is assumed that the increase in the TR-ab level is due to adrenalin-induced constriction of the capillaries in the thyroid tissues, resulting in a voluminous flow of the TR-ab retained in the thyroid into the vein. These findings indicate that the TR-ab level in the peripheral blood does not necessarily reflect precisely the abnormal immunological condition in the Graves' thyroid.

TSH Receptor Antibody (TRAb) Assays Based on the Human Monoclonal Autoantibody M22 are more Sensitive than Bovine TSH Based Assays

2009 ◽  
Vol 42 (01) ◽  
pp. 65-69 ◽  
Author(s):  
K. Zöphel ◽  
D. Roggenbuck ◽  
P. von Landenberg ◽  
G. Wunderlich ◽  
T. Grüning ◽  
...  
Keyword(s):  
Tsh Receptor ◽  
Receptor Antibody ◽  
Tsh Receptor Antibody ◽  
Monoclonal Autoantibody ◽  
Bovine Tsh

scholarly journals Changes in TSH-Receptor Antibody (TR-AB) and Thyroid Stimulating Antibody (TS-AB) after Thyroidectomy in Thyrotoxic Patients

1990 ◽  
Vol 66 (8) ◽  
pp. 727-736 ◽  
Author(s):  
Hiroyuki HOSOJIMA ◽  
Eiji MIYAUCHI ◽  
Hiroshi OKADA ◽  
Sadahide AZUKIZAWA ◽  
Ikuo YAMAMOTO ◽  
...  
Keyword(s):  
Tsh Receptor ◽  
Receptor Antibody ◽  
Thyroid Stimulating Antibody ◽  
Tsh Receptor Antibody

TSH receptor antibody-associated thyroid dysfunction following subacute thyroiditis

1998 ◽  
Vol 48 (4) ◽  
pp. 445-453 ◽  
Author(s):  
Makoto Iitaka ◽  
Naoko Momotani ◽  
Toshihiko Hisaoka ◽  
Jaeduk Yoshimura Noh ◽  
Naofumi Ishikawa ◽  
...  
Keyword(s):  
Thyroid Dysfunction ◽  
Subacute Thyroiditis ◽  
Tsh Receptor ◽  
Receptor Antibody ◽  
Tsh Receptor Antibody

scholarly journals Determinants of Extraocular Muscle Volume in Patients with Graves' Disease

2012 ◽  
Vol 2012 ◽  
pp. 1-4 ◽  
Author(s):  
Samer El-Kaissi ◽  
Jack R. Wall
Keyword(s):  
Extraocular Muscle ◽  
Tsh Receptor ◽  
Graves Disease ◽  
Thyroid Function Tests ◽  
Thyroid Scintigraphy ◽  
Free T4 ◽  
Receptor Antibody ◽  
Tsh Receptor Antibody ◽  
Antibody Positivity ◽  
Serum Tsh

Background. To examine factors contributing to extraocular muscle (EOM) volume enlargement in patients with Graves’ hyperthyroidism.Methods. EOM volumes were measured with orbital magnetic resonance imaging (MRI) in 39 patients with recently diagnosed Graves’ disease, and compared to EOM volumes of 13 normal volunteers. Thyroid function tests, uptake on thyroid scintigraphy, anti-TSH-receptor antibody positivity and other parameters were then evaluated in patients with EOM enlargement.Results. 31/39 patients had one or more enlarged EOM, of whom only 2 patients had clinical EOM dysfunction. Compared to Graves’ disease patients with normal EOM volumes, those with EOM enlargement had significantly higher mean serum TSH (0.020±0.005versus0.007±0.002mIU/L;Pvalue 0.012), free-T4 (52.9±3.3versus41.2±1.7 pmol/L;Pvalue 0.003) and technetium uptake on thyroid scintigraphy (13.51±1.7%versus8.55±1.6%;Pvalue 0.045). There were no differences between the 2 groups in anti-TSH-receptor antibody positivity, the proportion of males, tobacco smokers, or those with active ophthalmopathy.Conclusions. Patients with recently diagnosed Graves’ disease and EOM volume enlargement have higher serum TSH and more severe hyperthyroidism than patients with normal EOM volumes, with no difference in anti-TSH-receptor antibody positivity between the two groups.

scholarly journals Clinical course of euthyroid subjects with positive TSH receptor antibody: how often does Graves’ disease develop?

2021 ◽  
Author(s):  
Nami Suzuki ◽  
Akiko Kawaguchi ◽  
Jaeduk Yoshimura Noh ◽  
Ran Yoshimura ◽  
Kentaro Mikura ◽  
...  
Keyword(s):  
Thyroid Function ◽  
Clinical Course ◽  
Tsh Receptor ◽  
Graves Disease ◽  
Normal Thyroid ◽  
Receptor Antibody ◽  
Female Patients ◽  
Tsh Receptor Antibody ◽  
Normal Thyroid Function ◽  
Positive Results

Abstract Background Thyroid stimulating hormone (TSH) receptor antibody (TRAb) is detected in the serum of patients with Graves’ disease (GD). This study aims to investigate the prevalence of euthyroid individuals showing positive results for TRAb and to clarify the clinical course of thyroid function and TRAb levels in these subjects. Objective Subjects were female patients who newly visited our hospital for a screening test prior to fertility treatment and showed normal thyroid function and volume without nodules between 2014 and 2017. After excluding subjects with a history of thyroid disease, 5,622 subjects were analyzed. Results Forty-seven of the 5,622 subjects showed positive results for TRAb (reference range, < 2.0 IU/L) at the initial visit. Median initial TRAb was 2.9 IU/L (range, 2.0 -14.7 IU/L) and median follow-up was 18.3 months (range, 0- 66.5 months). Six of the 47 subjects (12.8%) developed GD and median duration until development was 6.6 months (range, 1.2 -13.2 months). Median TRAb values initially and at diagnosisof GD for those 6 patients were 3.7 IU/L (range, 2.7 -5.1 IU/L) and 7.2 IU/L (range 3.6 -21.4 IU/L), respectively. TRAb results turned negative for 20 of the 47 subjects, but remained positive despite normal thyroid function in 13 of the 47 subjects. Conclusion GD developed over time in 12.8% of euthyroid young female patients showing positive TRAb within a median of 6.6 months. A positive result for TRAb itself did not mean development of GD, so other factors must be essential for the pathogenesis of GD.

Sign in / Sign up

Export Citation Format

Share Document